DE68903713D1 - Dextrorphansalze enthaltende orale arzneimittel. - Google Patents

Dextrorphansalze enthaltende orale arzneimittel.

Info

Publication number
DE68903713D1
DE68903713D1 DE8989116906T DE68903713T DE68903713D1 DE 68903713 D1 DE68903713 D1 DE 68903713D1 DE 8989116906 T DE8989116906 T DE 8989116906T DE 68903713 T DE68903713 T DE 68903713T DE 68903713 D1 DE68903713 D1 DE 68903713D1
Authority
DE
Germany
Prior art keywords
dextrorphan
salts
products containing
medicinal products
oral medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989116906T
Other languages
English (en)
Other versions
DE68903713T2 (de
Inventor
Gianluigi Bandi
Mauro Valenti
Antonio Fossati
Carlo Passarotti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prodotti Formenti Srl
Original Assignee
Prodotti Formenti Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodotti Formenti Srl filed Critical Prodotti Formenti Srl
Publication of DE68903713D1 publication Critical patent/DE68903713D1/de
Application granted granted Critical
Publication of DE68903713T2 publication Critical patent/DE68903713T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8989116906T 1988-09-16 1989-09-13 Dextrorphansalze enthaltende orale arzneimittel. Expired - Lifetime DE68903713T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8821965A IT1226800B (it) 1988-09-16 1988-09-16 Composizioni farmaceutiche orali contenenti sali di destrorfano.

Publications (2)

Publication Number Publication Date
DE68903713D1 true DE68903713D1 (de) 1993-01-14
DE68903713T2 DE68903713T2 (de) 1993-04-01

Family

ID=11189490

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989116906T Expired - Lifetime DE68903713T2 (de) 1988-09-16 1989-09-13 Dextrorphansalze enthaltende orale arzneimittel.

Country Status (6)

Country Link
US (1) US5013554A (de)
EP (1) EP0359215B1 (de)
JP (1) JP2927833B2 (de)
AT (1) ATE82849T1 (de)
DE (1) DE68903713T2 (de)
IT (1) IT1226800B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
ATE209907T1 (de) * 1994-04-08 2001-12-15 Atrix Lab Inc Flüssige mittel zur wirkstoffabgabe
US11214544B2 (en) 2017-04-14 2022-01-04 Kempharm, Inc. Dextrorphan prodrugs and processes for making and using them

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2744112A (en) * 1952-06-30 1956-05-01 Hoffmann La Roche Preparation of optically active 3-hydroxy-n-methyl-morphinanes
US4126684A (en) * 1976-02-11 1978-11-21 Ciba-Geigy Corporation 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
US4454140A (en) * 1982-09-07 1984-06-12 Hoffmann-La Roche Inc. Nasal administration of dextromethorphan
IT1187743B (it) * 1985-09-26 1987-12-23 Prodotti Formenti Srl Composizioni farmaceutiche a base di destrorfano per applicazione instranasale
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4806543A (en) * 1986-11-25 1989-02-21 Board Of Trustees Of The Leland Stanford Junior University Method and compositions for reducing neurotoxic injury
US4906638A (en) * 1987-12-22 1990-03-06 Nova Pharmaceutical Corporation Dextromethorphan potentiator for anticonvulsant composition and method

Also Published As

Publication number Publication date
JPH02174715A (ja) 1990-07-06
IT1226800B (it) 1991-02-19
EP0359215A1 (de) 1990-03-21
EP0359215B1 (de) 1992-12-02
IT8821965A0 (it) 1988-09-16
DE68903713T2 (de) 1993-04-01
US5013554A (en) 1991-05-07
ATE82849T1 (de) 1992-12-15
JP2927833B2 (ja) 1999-07-28

Similar Documents

Publication Publication Date Title
IT1164550B (it) Prodotto medicinale da somministrare per via orale dotato di azione antiflogistica
SE8505112D0 (sv) Novel pharmacological compounds
DE3875425D1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
LV10082A (lv) Propenskabes atvasinajumi to iegusanas panemiens sastavs un pielietosana senisu kukainu un ercu apkarosanai
SE8700498L (sv) Nya farmakologiskt aktiva foreningar
KR880005932A (ko) 신경중독손상을 감소시키기 위한 약제 조성물
LV10953A (lv) Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
ITBO910113A0 (it) Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari
IT1197038B (it) Composizione farmaceutica ad attivita' analgesica
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
ITMI921930A1 (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
FR2674754B1 (fr) Composition medicamenteuse micronisee.
ES2056822T3 (es) Agentes inmunoestimulantes.
DE68903713D1 (de) Dextrorphansalze enthaltende orale arzneimittel.
DE3782378T2 (de) Dihydropyridinderivate und deren pharmazeutische zusammensetzungen.
ES368325A1 (es) Un procedimiento para la preparacion de un compuesto de ce-falosporina.
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
IT8721981A0 (it) Composizione farmaceutica antiinfiammatoria ad effetto prolungato ad uso topico
IT1156162B (it) Composizione antitumorale per via orale e procedimento per favorire il suo assorbimento da parte dell'intestino
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
IT1250629B (it) Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
ES2080445T3 (es) Derivados de ursano, su preparacion y formulaciones farmaceuticas de los mismos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee